Carmona-Sánchez R

Language: Spanish
References: 45
Page: 402
PDF size: 74.76 Kb.

Text Extraction

No abstract

REFERENCES

1. Carmona-Sánchez R, Solana-Sentíes S, Esmer-Sánchez D, Álvarez-Tostado F. La prevalencia de los diferentes grupos que integran la enfermedad por reflujo con endoscopia negativa. Rev Gastroenterol Méx 2005; 70: 6-13.

2. Remes-Troche JM, Carmona-Sánchez R, Soto-Pérez JC y cols. Utilidad del rabeprazol como prueba diagnóstica en la enfermedad por reflujo no erosiva. Rev Gastroenterol Méx 2005; 70: 276-83.

3. Tack J, Fass R. Review article: Approaches to endoscopic-negative reflux disease: part of the GERD-spectrum or an unique acid-related disorder? Aliment Pharmacol Ther 2004; 19(Suppl. 1): 28-34.

4. Fass R, Tougas G. Functional heartburn: the stimulus, the pain, and the brain. Gut 2002; 51: 885-92.

5. Avradopoulos KA, Vezeridis MP, Wanebo HJ. Pelvic exenteration for recurrent rectal cancer. Adv Surg 1996; 29: 215-33.

6. Meneu JC, Wanebo HJ, Nistal JA. Abdominosacral resection for locorregional recurrence rectal cancer. Rev Esp Enferm Dig 1999; 91: 374-9.

7. Guyot F, Faivre J, Manfredi S, Meny B, Bonithon-Kopp C, Bouvier AM. Time trends in the treatment and survival of recurrences from colorectal cancer. Ann Oncol 2005; 16: 756-61.

8. Schumpelick V, Braun J. Sacral recurrence of rectal carcinoma. Chirurg 1995; 66: 931-40.

9. Boyle KM, Sagar PM, Chalmers AG, et.al. Surgery for locally recurrent rectal cancer. Dis Colon Rectum 2005; 48: 929-37.

10. Yamada K, Ishizawa T, Niwa K, et al. Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer. Br J Surg 2001; 88: 988-93.

11. Taleky B. Abdominosacral resection of recurrent rectal cancer in the sacrum. Acta Chir Yugos 1998; 45: 45-7.

12. Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (ADULT TREATMENT PANEL III). JAMA 2001; 285: 2486-97.

13. Sundaram V, Northdup G, Nadkarmi M, et al. Metabolic syndrome is a major risk factor for NAFLD among patients with non-insulin dependent diabetes mellitus. Gastroenterology 2006; 130(Suppl. 2): A-824.

14. Duseja A, Sialy R, Das A, et al. Insulin tolerance test is comparable to homeostasis model of assessment for insulin resistance in patients with NAFLD. Gastroenterology 2006; 130 (Suppl. 2): A-821.

15. Aggarwal R, Kumar M, Berger R, et al. Racial differences in the prevalence of elevated ALT levels in obese patients. Gastroenterology 2006; 130(Suppl. 2): A-820.

16. Attar BM, Halliburton C, Chinga-Alayo E. Correlation of ultrasonography and histology in patients with steatosis. Gastroenterology 2006; 130(Suppl 2): A-595.

17. Boland R. Decoding hereditary colorectal cancer. N Engl J Med 2006; 354: 2815-17.

18. Lynch HT, Lynch PM. Molecular screening for the Lynch syndrome- better than family history? N Engl J Med 2005; 352: 1920-2.

19. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003; 348: 919-32.

20. Schmeler KM, LynchHT, Chem L, et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 2006; 354: 261-9.

21. Robles-Díaz G, Duarte-Rojo A. Cáncer de páncreas: etiología y detección temprana. En: Valdovinos MA, Milke P, Uscanga L (eds.). Gastroenterología, Hepatología y Nutrición basadas en evidencias. 1a. Ed. México: Masson Doyma; 2002, p. 177-92.

22. Apte MV, Pirola RC, Wilson JS. Where there’s smoke there’s not necessarily fire. Gut 2005; 54: 446-7.

23. Maisonneuve P, Lowenfels AB, Müllhaupt B, et al. Cigarette smoking accelerates progression of alcoholic chronic pancreatitis. Gut 2005; 54: 510-4.

24. Peláez-Luna M, Guerrero I, Robles-Díaz G. Cigarette smoking delays the onset and diagnosis of chronic pancreatitis (CP). Pancreas 2004; 29: 342-3.

25. Chiarioni G, Salandini L, Whitehead WE. Biofeedback benefits only patients UIT outlet dysfunction, not patients with isolated slow transit constipation. Gastroenterology 2005; 129: 86-97.

26. Battaglia E, Serra AM, Buonafede G, et al. Long-term study on the effects of visual biofeedback and muscle training as a therapeutic modality in pelvic floor dyssynergia and slow-transit constipation. Dis Colon Rectum 2004; 47: 90-5.

27. Lembo A, Camilleri M. Chronic Constipation. N Engl J Med 2003; 349: 1360-8.

28. Brisinda G, Cadeddu F, Maria G., Chronic constipation. N Engl J Med. 2004; 350: 1260.

29. Rao S. Constipation: Evaluation and treatment. Gastroenterol Clin N Am 2003; 32: 659-685.

30. Bharucha AE, Wald A, Enck P, Rao S. Functional anorectal disorders. Gastroenterology 2006; 130: 1510-18.

31. Voskuijl W, Lorijn F, Verwijs, et al. PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: A double blind, randomized, controlled, multicentre trial. Gut 2004; 53: 1590-4.

32. Marrufo-García CA, Sánchez-Avila MT, Morales-Garza LA, et al. Manometría y defecografía en el paciente constipado con disquecia. Rev Gastroenterol Mex 2005; 70, 4: 424-9.

33. Pennazio M. Small-bowel endoscopy. Endoscopy 2004; 36: 32-41.

34. Hahne M, Adamek HE, Schilling D, et al. Wireless capsule endoscopy in a patient with obscure occult bleeding. Endoscopy 2002; 34: 588-90.

35. Iddan G, Meron G, Glukhovsky A, et al. Wireless capsule endoscopy. Nature 2000; 405: 17.

36. Appleyard M, Glukhovsky A, Swain P. Wireless-capsule diagnostic endoscopy for recurrent small-bowel bleeding. N Engl J Med 2001; 344: 232-3.

37. Yamamoto H, Sekine Y, Sato Y, et al. Total enteroscopy with a nonsurgical steerable double-ballon method. Gastrointest Endosc 2001; 53: 216-20.

38. Yamamoto H, Yano T, Kita H, et al. New system of double-ballon enteroscopy for diagnosis and treatment of small intestinal disorders. Gastroenterology 2004; 125: 1556-7.

39. May A, Nachbar L, Wardak A. Double-balloon enteroscopy in patients with obscure gastrointestinal bleeding and/or chronic abdominal pain. Gastrointest Endoscopy 2004; 59: B 155.

40. Groonlund MM, Lehtonen OP, Enrola E, Kero P. Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora alter cesarean delivery. J Pediatr Gastroenterol Nutr 1999; 28: 19-25.

41. Mackie R, Sghir A, Gaskins H R. Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr 1999; 69(Suppl.): 1035S-45S.

42. Yoshioka H, Iseki K, Fujita K. Development and differences of intestinal flora in the neonatal period in breast-fed and bottle-fed infants. Pediatrics 1983; 72: 317-21.

43. Köhler H, Donarski S, Stocks B, et al. Antibacterial characteristics in the feces of breast-fed and formula-fed infants during the first year of life. J Pediatr Gastroent Nutr 2002; 34: 188-93.

44. Gueimonde M, Kalliomäki M, Isolauri E, Selminen S. Probiotic intervention in neonates-will permanent colonization ensue? J Pediatr Gastroenterol Nutr 2006; 42: 604-6.

45. Knol J, Scholtens P, Kafka C, et al. Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast-fed infants. J Pediatr Gastroenterol Nutr 2005 40: 36-42.